IBEX LTD (IBEX) Fundamental Analysis & Valuation
NASDAQ:IBEX • BMG4690M1010
29.34 USD
+0.3 (+1.03%)
Last: Mar 4, 2026, 01:50 PM
This IBEX fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 7 out of 10 to IBEX. IBEX was compared to 86 industry peers in the IT Services industry. IBEX gets an excellent profitability rating and is at the same time showing great financial health properties. An interesting combination arises when we look at growth and value: IBEX is growing strongly while it also seems undervalued. These ratings would make IBEX suitable for value and growth and quality investing!
1. IBEX Profitability Analysis
1.1 Basic Checks
- IBEX had positive earnings in the past year.
- In the past year IBEX had a positive cash flow from operations.
- Each year in the past 5 years IBEX has been profitable.
- IBEX had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- The Return On Assets of IBEX (14.98%) is better than 94.19% of its industry peers.
- IBEX's Return On Equity of 28.69% is amongst the best of the industry. IBEX outperforms 89.53% of its industry peers.
- IBEX has a Return On Invested Capital of 21.96%. This is amongst the best in the industry. IBEX outperforms 95.35% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.98% | ||
| ROE | 28.69% | ||
| ROIC | 21.96% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a decent Profit Margin value of 7.35%, IBEX is doing good in the industry, outperforming 70.93% of the companies in the same industry.
- IBEX's Profit Margin has improved in the last couple of years.
- Looking at the Operating Margin, with a value of 9.38%, IBEX is in the better half of the industry, outperforming 66.28% of the companies in the same industry.
- IBEX's Operating Margin has improved in the last couple of years.
- IBEX has a Gross Margin (30.36%) which is comparable to the rest of the industry.
- In the last couple of years the Gross Margin of IBEX has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9.38% | ||
| PM (TTM) | 7.35% | ||
| GM | 30.36% |
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
2. IBEX Health Analysis
2.1 Basic Checks
- IBEX has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- IBEX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 4.85 indicates that IBEX is not in any danger for bankruptcy at the moment.
- With a decent Altman-Z score value of 4.85, IBEX is doing good in the industry, outperforming 79.07% of the companies in the same industry.
- The Debt to FCF ratio of IBEX is 0.05, which is an excellent value as it means it would take IBEX, only 0.05 years of fcf income to pay off all of its debts.
- IBEX has a better Debt to FCF ratio (0.05) than 91.86% of its industry peers.
- IBEX has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
- The Debt to Equity ratio of IBEX (0.00) is better than 84.88% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Altman-Z | 4.85 |
ROIC/WACC2.32
WACC9.45%
2.3 Liquidity
- IBEX has a Current Ratio of 1.83. This is a normal value and indicates that IBEX is financially healthy and should not expect problems in meeting its short term obligations.
- Looking at the Current ratio, with a value of 1.83, IBEX is in line with its industry, outperforming 53.49% of the companies in the same industry.
- A Quick Ratio of 1.83 indicates that IBEX should not have too much problems paying its short term obligations.
- IBEX has a Quick ratio (1.83) which is in line with its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 |
3. IBEX Growth Analysis
3.1 Past
- IBEX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.77%, which is quite impressive.
- Measured over the past years, IBEX shows a very strong growth in Earnings Per Share. The EPS has been growing by 41.04% on average per year.
- The Revenue has grown by 15.63% in the past year. This is quite good.
- IBEX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 6.62% yearly.
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
Revenue 1Y (TTM)15.63%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
3.2 Future
- Based on estimates for the next years, IBEX will show a quite strong growth in Earnings Per Share. The EPS will grow by 13.72% on average per year.
- IBEX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 9.67% yearly.
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year13.82%
Revenue Next 2Y9.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. IBEX Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 8.48, the valuation of IBEX can be described as reasonable.
- Based on the Price/Earnings ratio, IBEX is valued cheaply inside the industry as 88.37% of the companies are valued more expensively.
- When comparing the Price/Earnings ratio of IBEX to the average of the S&P500 Index (26.83), we can say IBEX is valued rather cheaply.
- Based on the Price/Forward Earnings ratio of 8.10, the valuation of IBEX can be described as reasonable.
- IBEX's Price/Forward Earnings ratio is rather cheap when compared to the industry. IBEX is cheaper than 90.70% of the companies in the same industry.
- IBEX is valuated cheaply when we compare the Price/Forward Earnings ratio to 24.95, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.48 | ||
| Fwd PE | 8.1 |
4.2 Price Multiples
- IBEX's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. IBEX is cheaper than 90.70% of the companies in the same industry.
- IBEX's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. IBEX is cheaper than 74.42% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.44 | ||
| EV/EBITDA | 5.05 |
4.3 Compensation for Growth
- IBEX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- IBEX has a very decent profitability rating, which may justify a higher PE ratio.
- IBEX's earnings are expected to grow with 13.72% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.37
PEG (5Y)0.21
EPS Next 2Y13.72%
EPS Next 3YN/A
5. IBEX Dividend Analysis
5.1 Amount
- IBEX does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
IBEX Fundamentals: All Metrics, Ratios and Statistics
NASDAQ:IBEX (3/4/2026, 1:50:29 PM)
29.34
+0.3 (+1.03%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)02-05 2026-02-05/amc
Earnings (Next)05-06 2026-05-06/amc
Inst Owners94.08%
Inst Owner Change3.56%
Ins Owners2.8%
Ins Owner Change14.97%
Market Cap393.45M
Revenue(TTM)603.27M
Net Income(TTM)44.32M
Analysts45.71
Price Target41.82 (42.54%)
Short Float %1.24%
Short Ratio1.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.35%
Min EPS beat(2)8.65%
Max EPS beat(2)20.05%
EPS beat(4)4
Avg EPS beat(4)15.36%
Min EPS beat(4)8.65%
Max EPS beat(4)21.85%
EPS beat(8)8
Avg EPS beat(8)15.45%
EPS beat(12)10
Avg EPS beat(12)11.12%
EPS beat(16)13
Avg EPS beat(16)15.27%
Revenue beat(2)2
Avg Revenue beat(2)3.02%
Min Revenue beat(2)2.5%
Max Revenue beat(2)3.54%
Revenue beat(4)4
Avg Revenue beat(4)4.92%
Min Revenue beat(4)2.5%
Max Revenue beat(4)8.52%
Revenue beat(8)6
Avg Revenue beat(8)2.69%
Revenue beat(12)6
Avg Revenue beat(12)0.39%
Revenue beat(16)7
Avg Revenue beat(16)-0.19%
PT rev (1m)0%
PT rev (3m)6.49%
EPS NQ rev (1m)-2.2%
EPS NQ rev (3m)-2.2%
EPS NY rev (1m)0%
EPS NY rev (3m)5.47%
Revenue NQ rev (1m)0.91%
Revenue NQ rev (3m)0.91%
Revenue NY rev (1m)0.89%
Revenue NY rev (3m)2.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.48 | ||
| Fwd PE | 8.1 | ||
| P/S | 0.65 | ||
| P/FCF | 13.44 | ||
| P/OCF | 6.66 | ||
| P/B | 2.55 | ||
| P/tB | 2.76 | ||
| EV/EBITDA | 5.05 |
EPS(TTM)3.46
EY11.79%
EPS(NY)3.62
Fwd EY12.34%
FCF(TTM)2.18
FCFY7.44%
OCF(TTM)4.41
OCFY15.02%
SpS44.99
BVpS11.52
TBVpS10.64
PEG (NY)0.37
PEG (5Y)0.21
Graham Number29.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.98% | ||
| ROE | 28.69% | ||
| ROCE | 27.05% | ||
| ROIC | 21.96% | ||
| ROICexc | 23.71% | ||
| ROICexgc | 25.25% | ||
| OM | 9.38% | ||
| PM (TTM) | 7.35% | ||
| GM | 30.36% | ||
| FCFM | 4.85% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y27.75%
OM growth 5Y12.6%
PM growth 3Y14.82%
PM growth 5Y27.95%
GM growth 3Y0.55%
GM growth 5YN/A
F-Score8
Asset Turnover2.04
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0.05 | ||
| Debt/EBITDA | 0.01 | ||
| Cap/Depr | 168.3% | ||
| Cap/Sales | 4.94% | ||
| Interest Coverage | 42.98 | ||
| Cash Conversion | 79.5% | ||
| Profit Quality | 66.06% | ||
| Current Ratio | 1.83 | ||
| Quick Ratio | 1.83 | ||
| Altman-Z | 4.85 |
F-Score8
WACC9.45%
ROIC/WACC2.32
Cap/Depr(3y)83.97%
Cap/Depr(5y)108.52%
Cap/Sales(3y)2.89%
Cap/Sales(5y)3.72%
Profit Quality(3y)75.63%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.77%
EPS 3Y28.16%
EPS 5Y41.04%
EPS Q2Q%47.46%
EPS Next Y22.95%
EPS Next 2Y13.72%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)15.63%
Revenue growth 3Y4.24%
Revenue growth 5Y6.62%
Sales Q2Q%16.73%
Revenue Next Year13.82%
Revenue Next 2Y9.67%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y17.68%
EBIT growth 3Y33.16%
EBIT growth 5Y20.06%
EBIT Next Year68.46%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y50.53%
FCF growth 3Y24.66%
FCF growth 5Y-10.09%
OCF growth 1Y85.57%
OCF growth 3Y4.51%
OCF growth 5Y-2.46%
IBEX LTD / IBEX FAQ
Can you provide the ChartMill fundamental rating for IBEX LTD?
ChartMill assigns a fundamental rating of 7 / 10 to IBEX.
What is the valuation status for IBEX stock?
ChartMill assigns a valuation rating of 8 / 10 to IBEX LTD (IBEX). This can be considered as Undervalued.
What is the profitability of IBEX stock?
IBEX LTD (IBEX) has a profitability rating of 7 / 10.
What is the valuation of IBEX LTD based on its PE and PB ratios?
The Price/Earnings (PE) ratio for IBEX LTD (IBEX) is 8.48 and the Price/Book (PB) ratio is 2.55.
Is the dividend of IBEX LTD sustainable?
The dividend rating of IBEX LTD (IBEX) is 0 / 10 and the dividend payout ratio is 0%.